• AO/PI Staining Solution: Advanced Cell Viability Analysis in

  2026-07-22

  Explore the scientific foundation and advanced applications of AO/PI Staining Solution for precise live/dead cell discrimination using fluorescent DNA dyes. This article uniquely connects assay optimization to disease model research, providing actionable insights for modern laboratories.

• Cy5 TSA Fluorescence System Kit: Precision Signal Amplificat

  2026-07-22

  The Cy5 TSA Fluorescence System Kit delivers rapid, HRP-catalyzed tyramide deposition for 100-fold signal amplification in immunohistochemistry and in situ hybridization. Its unique chemistry enables detection of low-abundance targets with high specificity and minimal antibody consumption. The kit is validated for robust, reproducible fluorescence enhancement across diverse molecular biology workflows.

• JHU-083: Advancing Redox Biology and Glutaminase Targeting

  2026-07-21

  Explore how JHU-083, a 6-diazo-5-oxo-L-norleucine precursor, is reshaping experimental cerebral malaria and neurological disease models through selective glutaminase inhibition and redox pathway modulation. This article uniquely bridges glutaminase pathway research with emerging redox-targeted therapeutic strategies.

• EPI-001: Androgen Receptor N-Terminal Domain Inhibitor in On

  2026-07-21

  EPI-001 enables precise inhibition of androgen receptor signaling—including resistant ARv7 variants—advancing research in prostate and triple-negative breast cancer. Its unique domain targeting and robust workflow compatibility set it apart for translational and mechanistic studies.

• Dabigatran Etexilate: Advances in Oral Anticoagulation and D

  2026-07-20

  Dabigatran etexilate represents a major advance in anticoagulation therapy by offering a direct thrombin inhibitor that is orally bioavailable and does not depend on cytochrome P450 metabolism. This innovation reduces the risk of drug-drug interactions and streamlines anticoagulation management, as detailed in the reference review. Its pharmacological profile also offers new opportunities in designing studies on drug metabolism and interaction.

• FGFR and TGFβ/PI3K/AKT Cross Talk Regulates Periostin in HER

  2026-07-20

  Labrèche et al. reveal that periostin expression in HER2-positive breast cancer cells is controlled by a complex interplay between FGFR, TGFβ, and PI3K/AKT signaling pathways. This mechanistic insight clarifies the cellular regulation of periostin, highlighting new angles for understanding tumor progression and therapeutic intervention.

• Syringin in Advanced Natural Product Research: Novel Mechani

  2026-07-19

  Explore the unique properties and mechanistic breakthroughs of Syringin, a bioactive natural product, in cutting-edge apoptosis and signaling pathway research. This article delivers fresh, practical perspectives for protocol design and bioactive compound screening.

• GSTA1-Mediated Glutathione Depletion in α-Amanitin Hepatotox

  2026-07-18

  The reference study reveals a paradoxical mechanism wherein GSTA1, typically a detoxifying enzyme, intensifies α-amanitin-induced liver injury by depleting glutathione and exacerbating oxidative stress. These findings identify GSTA1 as both a direct pathogenic factor and a potential therapeutic target in acute amatoxin poisoning, informing future research on redox modulation strategies.

• CNQX in Neural Circuit Dissection: Mechanistic Insights & Li

  2026-07-17

  Explore the nuanced role of CNQX as a glutamatergic neurotransmission inhibitor, delving into its selective receptor antagonism and assay implications. This article uniquely analyzes mechanistic findings and cross-domain evidence, offering advanced guidance for neuroscience research.

• GSTA1 Aggravates Glutathione Loss in α-Amanitin Hepatotoxici

  2026-07-17

  This study reveals that GSTA1, typically a hepatic detoxifier, paradoxically exacerbates oxidative stress and cell death during α-amanitin-induced liver injury by depleting glutathione. These insights propose GSTA1 as both a mechanistic driver and a potential therapeutic target in acute hepatotoxicity, with implications for the study of redox regulation and glutathione metabolism.

• JHU-083: A 6-Diazo-5-oxo-L-norleucine Precursor for Glutamin

  2026-07-16

  JHU-083, a highly pure 6-diazo-5-oxo-L-norleucine precursor, empowers researchers to dissect glutaminase pathways in neuroinflammatory and excitotoxic disease models. Its unique selectivity for cerebral CD11b cells, robust solubility profile, and high-quality validation make it an indispensable tool for experimental cerebral malaria and beyond.

• JHU-083: Advancing 6-diazo-5-oxo-L-norleucine Precursor Rese

  2026-07-16

  JHU-083 enables selective targeting of cerebral glutaminase, redefining experimental workflows for neurological disease and redox imbalance models. Integrating recent insights into GSTA1-mediated glutathione depletion, this article offers actionable guidance for optimizing metabolic and excitotoxicity assays using APExBIO’s high-purity compound.

• WNT5a/GSK3/β-Catenin Axis Regulates FAP Adipogenesis in Musc

  2026-07-15

  This study reveals the central regulatory role of the WNT5a/GSK3/β-catenin axis in controlling adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological, single-cell, and transcriptomic approaches, the authors demonstrate that modulating this pathway can limit pathological fat infiltration in muscle, offering new avenues for research on muscular dystrophies and tissue regeneration.

• UHRF1-Mediated DNA Methylation Impairs Osteogenesis in SOP

  2026-07-15

  This study uncovers how UHRF1-driven DNA 5-methylcytosine modification disrupts super-enhancer landscapes and impairs osteogenic differentiation in senile osteoporosis via TGM2-regulated autophagic flux. These mechanistic insights reveal new epigenetic intervention points for age-related bone loss and advance our understanding of MSC dysfunction in osteoporosis.

• Sodium Citrate (SKU B7298): Reliable Solutions in SERS and C

  2026-07-14

  This scenario-driven article guides biomedical researchers and lab technicians through real laboratory challenges where Sodium Citrate (SKU B7298) delivers validated, data-backed solutions. Integrating recent advances in SERS nanocluster fabrication and cell-based workflows, it highlights how high-purity sodium 2-hydroxypropane-1,2,3-tricarboxylate from APExBIO ensures reproducibility and workflow robustness.

15991 records 1/1067 page Next 12345 下5页 Last page